# International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study

> **NCT04330963** · — · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 600 (estimated)

## Conditions studied

- Narcolepsy
- Idiopathic Hypersomnia
- Hypersomnolence Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04330963
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-06
- **Primary completion:** 2024-12-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2023-04-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04330963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04330963, "International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04330963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*